Journal of Virology, October 1998, p. 8158-8165, Vol. 72, No. 10
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Department of Laboratory Medicine, University of Washington, Seattle, Washington 981951; Program in Infectious Diseases, Fred Hutchinson Cancer Research Center, Seattle, Washington 981042; ChemoCentryx, Mountain View, California 940433; and Divisions of Molecular Medicine and Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington 981094
Received 16 January 1998/Accepted 10 July 1998
| |
ABSTRACT |
|---|
|
|
|---|
The protein encoded by the US28 gene of human cytomegalovirus
(HCMV) has homology to G protein-coupled receptors (GCR). Previous studies demonstrated that recombinant US28 protein can bind the
class of chemokines (K. Neote, D. DiGregorio, J. Y. Mak, R. Horuk,
and T. J. Schall, Cell 72:415-425, 1993) and induce a rise in
intracellular calcium after the binding of chemokines (J. L. Gao
and P. M. Murphy, J. Biol. Chem. 269:28539-28542, 1994). In order to investigate the function of the US28 protein in virus-infected cells, a recombinant HCMV (HV5.8) was constructed, with the US28 open
reading frame disrupted by the insertion of the Escherichia coli
gpt gene and the gene for the green fluorescent protein. The US28
gene is not required for growth in human fibroblasts (HF). HF infected
with wild-type HCMV bound RANTES at 24 h postinfection and
demonstrated an intracellular calcium flux induced by RANTES. In cells
infected with HV5.8, RANTES did not bind or induce a calcium flux,
demonstrating that US28 is responsible for the
-chemokine binding
and induced calcium signaling in HCMV-infected cells. The ability of
the US28 gene to bind chemokines was shown to cause a significant
reduction in the concentration of RANTES in the medium of infected
cells. Northern analysis of RNA from infected cells showed that US28 is
an early gene, while US27 (another GCR) is a late gene.
| |
INTRODUCTION |
|---|
|
|
|---|
Open reading frames (ORF) with homology to cellular seven transmembrane spanning receptors have been identified in the genomes of both beta and gamma herpesviruses (15, 37). Many cellular seven transmembrane spanning receptors have been shown to be G protein-coupled receptors (GCR) and comprise a superfamily of genes encoding the receptors for a variety of biological compounds, including neurotransmitters, hormones, odorants, and chemotactic agents. GCR link the binding of an extracellular ligand to processes within the cell by their activation of associated G proteins. G proteins can activate serine/threonine kinases, phosphatidylinositol 3-kinase, phospholipases, or Ras (9). These proteins, in turn, can stimulate mitogen-activated protein kinase or generate second messenger molecules, such as diacylglycerol and inositol triphosphate, resulting in the activation of protein kinase C and increases in intracellular Ca2+ levels (9). Ultimately, these processes result in the amplification of the initial signal transduced by the ligand-GCR interaction into complex cellular processes such as chemotaxis.
GCR are receptors for chemokines, derived from chemotactic cytokine, a
multigene family of 70- to 90-amino-acid soluble proteins that are
excreted from a variety of cell types and play important roles in
leukocyte trafficking and immune regulation (7). Two classes
of these structurally similar proteins are defined by the first two of
four conserved cysteines. In the
class (e.g., interleukin-8
[IL-8], MGSA, and GCP-2) the first two cysteines are separated by an
intervening residue (C-X-C), while in the
class (e.g., RANTES,
MIP-1
, MIP-1
, and MCP-1) they are adjacent (C-C). In general, the
-chemokines attract primarily neutrophils, while
-chemokines can
have activity on monocytes, lymphocytes, eosinophils, and basophils
(46).
The human cytomegalovirus (HCMV) US28 ORF shows approximately 33%
homology to the cellular
-chemokine receptor CCR-1 (35). Conserved features of viral and cellular proteins include the putative
seven-membrane spanning regions and cysteines implicated in disulfide
bond formation. The sequence homology between US28 and cellular GCR led
to the identification of
-chemokines as the ligand for the viral
receptor. Recombinant HCMV US28 protein expressed in 293 cells was
shown to bind
-chemokines (35), and as with the binding
of chemokines by their cellular receptors, the binding of ligand by
recombinant US28 expressed in K562 cells led to an increase in
intracellular calcium (21).
During an acute infection, HCMV can be found in the blood as well as in numerous tissues, with the lungs, kidneys, salivary gland, and liver being commonly involved. HCMV has been identified in a wide variety of cells both in culture and in patients' tissue, including epithelial cells, endothelial cells, fibroblasts, monocytes/macrophages, and lymphocytes (33, 47, 52). Because HCMV can infect cell types that respond to chemokines and cell types that produce chemokines, the viral GCR may mimic the functions of cellular GCR, but the role of the expression of a viral GCR in viral biology and the cell type in which it is important are not known.
While researchers examined US28 function with recombinant protein in previous studies (21, 36), we have investigated the functions of the US28 gene expressed from the viral genome. We have constructed a recombinant HCMV with the US28 ORF disrupted by the genes for the green fluorescent protein (GFP) and guanine phosphoribosyl transferase (GPT) and have demonstrated that US28 is responsible for the functions of a GCR in HCMV-infected cells.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Cells and viruses. Human foreskin fibroblasts (HF) were grown in Dulbecco's modified Eagle's medium (Gibco Laboratories) supplemented with 10% Nu serum (Collaborative Research, Inc.), 0.1 mg of streptomycin, 100 U of penicillin, and 2 mM L-glutamine in a humidified 5% CO2 37°C incubator. HCMV (Towne) was used for all experiments.
Construction of recombinant virus.
The 6-kb BamHI
Q fragment (216298 to 222296 of the published sequence
[14]) of AD169 was cloned into the BamHI
site of pOK7 to generate pQ62. A deletion was then generated between
the BspHI (219198) and the StuI (219627) sites
contained within the BamHI Q fragment to create pQ63. This
construct, pQ63, was digested with BclI and a 2.5-kb
BamHI fragment consisting of the Escherichia coli
gpt gene expressed by the herpes simplex virus (HSV) tk promoter and the GFP gene under the control of the rat
-actin promoter was
inserted into the BclI site (position 219666) to create
pQ64. For the transfection of HF, pQ64 was digested with
BamHI, extracted with phenol-CHCl3 and CHCl3, ethanol
precipitated, and dried. The DNA was resuspended in STE (5 mM NaCl, 5 mM Tris-HCl [pH 7.5], 1 mM EDTA) at a concentration of 1 to 2 mg/ml,
and 20 µg was used per electroporation. For electroporation, HF were
trypsinized, mixed with an equal volume of medium, pelleted at 500 × g for 5 min, and resuspended in electroporation buffer (a
1:3 mixture of OptiMEM I [Gibco] and cytomix [54]
[120 mM KCl, 0.15 mM CaCl2, 10 mM
K2HPO4-KH2PO4 [pH
7.6], 5 mM MgCl2]). In 0.4 ml of electroporation buffer
2 × 106 to 5 × 106 HF cells plus
DNA were electroporated with a BTX ECM 600 instrument set at 285 V and
1,075 µF in a 4-mm cuvette at room temperature. Cells were plated
following electroporation and infected with HCMV at a multiplicity of
infection (MOI) of 2 to 5 at 18 to 24 h postelectroporation.
Progeny virus from these cultures, harvested 5 days postinfection
(dpi), was used to infect fresh HF and cultured in medium containing 25 µg of xanthine per ml and 15 µg of mycophenolic acid per ml. Virus
was harvested 2 days post-100% cytopathic effect, and selection with
mycophenolic acid was repeated. Progeny virus from the second
mycophenolic acid selection was then used to plaque purify recombinant
virus by twofold-limiting dilution in 96-well plates. Recombinant virus
was identified as green fluorescent plaque under 450- to 490-nm UV
illumination.
-D-galactopyranoside) overlay as described previously (49). HV5.7, which has only the insertion of the 240-bp simian virus 40 (SV40) polyadenylation signal (position 2533 to 2770) at the BclI site, was
generated from HV5.6 with back selection against the gpt
gene with the drug 6-thioguanine by growing HV5.6 in human Lesch-Nyhan
(hypoxanthine-GPT deficient) skin fibroblasts (25). The
generation of HV5.7 is possible because the LacZ-GPT cassette of pON855
is flanked by direct repeats of the SV40 polyadenylation signals and
recombination can occur between these two repeated sequences, deleting
the LacZ and GPT genes, making the virus resistant to 6-thioguanine,
and leaving a single SV40 polyadenylation signal as the insert
(41, 56). Genome structure of these recombinant HCMV was
confirmed by viral DNA analysis as described previously for HV5.8 (data not shown).
Radioligand binding and displacement. Displaceable binding of 125I-labeled chemokine was performed on HF at various times after infection. Cells (2 × 106 cells per ml) were incubated with 0.5 nM radiolabeled ligands and varying concentrations of unlabeled ligands at 4°C for 2 h. The incubation was terminated by removing aliquots from the cell suspension and separating cells from buffer by centrifugation through a silicon-paraffin oil mixture (43). Nonspecific binding was determined in the presence of 1 mM unlabeled ligand. Individual assay determinations, representative of at least three separate experiments, are plotted. Iodine-labeled chemokines were obtained from Dupont/NEN (Boston, Mass.), and unlabeled chemokines were obtained from R&D Systems (Minneapolis, Minn.). Both homologous and heterologous chemokine displacements were measured. Experiments were carried out with two independently isolated recombinant viruses.
Cytoplasmic calcium measurements. HF were loaded with 2 mM indo-1/AM (Molecular Probes, Inc., Eugene, Oreg.) in complete growth medium at 20°C for 45 min. Cells were then washed, resuspended in Na-Hanks balanced salt solution (2 mM CaCl2, 145 mM NaCl, 5 mM KCl, 1 mM MgCl2, 5 mM glucose, 20 mM HEPES, pH 7.3) containing 1% bovine serum albumin and maintained at 20°C for up to 2 h. Approximately 5 × 105 cells were then suspended in 2 ml of Na-Hanks balanced salt solution and maintained at 37°C in a constantly stirred acrylic cuvette. Fluorescence measurements to determine the increase in cytosolic-free Ca2+ concentration ([Ca2+]i) were done with a Photon Technologies Inc. spectrofluorimeter with an excitation wavelength of 350 nm (4-nm bandwidth) and dual simultaneous monitoring of emission at 405 and 485 nm (10-nm bandwidth). The ratio of emission at 405 and 485 nm was measured at a rate of 2 Hz. Experiments were carried out with two independently isolated recombinant viruses.
RNA analysis. HF in 60-mm-diameter dishes were infected at an MOI of 5 PFU/cell. When used, ganciclovir (30 µm) was added to the culture medium 1 h before infection. At various times postinfection, whole-cell RNA was harvested (16) and analyzed by formaldehyde agarose gel electrophoresis and Northern hybridization (22) with a 32P-labeled probe. The US27 probe included the sequence from 217761 to 219008 of the AD169 sequence, and the US28 probe was composed of a PCR-generated clone of the US28 ORF (36).
Determination of RANTES concentration in culture
supernatants.
HF seeded in 15.5-mm wells were infected at an MOI
of 3, with Towne, HV5.8, UV-inactivated Towne, or heat-inactivated
Towne (60°C, 20 min) or left uninfected. At the end of 1 h of
absorption, the inoculum was removed and the cells washed with
phosphate-buffered saline, and 0.3 ml of medium was added to each well.
For each experimental interval, the medium was removed from the culture and 0.3 ml of fresh medium was added. The collected medium was centrifuged for 5 min at 1,500 × g, and the
supernatant was removed to a fresh tube and stored at
70°C until
analyzed. The RANTES concentration was determined with an enzyme-linked
immunosorbent assay kit for RANTES (R&D Systems) following the
manufacturer's instructions.
| |
RESULTS |
|---|
|
|
|---|
Construction and analysis of recombinant HCMV.
The steps for
the construction of HV5.8, a recombinant HCMV (Towne) with the
disruption of the US28 ORF by a deletion and the insertion of a GPT-GFP
cassette, are diagrammed in Fig. 1. The
construct used to construct HV5.8, pQ64, consisted of the BamHI Q fragment (position 216298 to 222296 of the Ad169
sequence) with a deletion of the first 40% of the US28 ORF between
positions 219200 (BspHI) and 219629 (StuI). A
GPT-GFP cassette was inserted at position 219666 (BclI)
within the US28 ORF. The GPT-GFP construct (Fig. 1) contains the
E. coli gpt gene expressed by the HSV thymidine kinase
promoter (55) and the GFP gene (13) expressed
from the rat
-actin promoter (38). The transcripts of
both genes are terminated by early polyadenylation signals of the
bidirectional SV40 polyadenylation signals (12), which can
provide polyadenylation functions for viral genes upstream of the
insertion site (55). HV5.8 was generated by pQ64-transfected
HF, which were subsequently infected with HCMV (Towne). Progeny virus
was grown under selection for the gpt gene for two cycles,
and recombinant virus containing the GFP was plaque purified by the
identification of green fluorescent plaques under 450- to 490-nm
illumination.
|
|
-actin promoter. The use of the GFP as a marker for
recombinant virus allows the visualization of infected cells by
fluorescent microscopy (Fig. 3). In
addition, the presence of the GFP makes possible the sorting of
infected cells by fluorescence-activated cell sorting, sorted cells
remained viable, and recombinant virus could be recovered (data not
shown).
|
|
Chemokine binding.
To determine if HCMV-infected cells would
show specific chemokine binding, experiments with labeled chemokines as
ligands were performed. HF infected with HCMV 24 and 48 h
postinfection were incubated with 125I-RANTES and
increasing amounts of unlabeled RANTES. The amount of labeled RANTES
bound to the cells was determined, showing that 125I-RANTES
bound to HCMV-infected cells, and this binding was prevented by
competition with unlabeled RANTES (Fig.
5A and B). HF and HF infected with HV5.8
or HV5.7 at 24 or 48 h postinfection did not demonstrate
125I-RANTES binding (Fig. 5A and B). This binding was
specific for
-chemokines in that MCP-1, like unlabeled RANTES, could
compete with labeled RANTES binding, but IL-8 did not (Fig. 5C). In
addition, cells 4 h postinfection with wild-type HCMV or HV5.8 did
not show increased RANTES binding compared to uninfected cells (data
not shown). The lack of chemokine binding by cells infected by both HV5.8 and HV5.7 supports the finding that US28 is the protein responsible for
-chemokine binding by infected cells.
|
Calcium flux. To test if the US28 ORF, expressed from the viral genome, was responsible for the induction of a calcium flux, the intracellular calcium level in HF infected with HCMV (Towne) or HV5.8 was monitored upon the addition of various chemokines. Changes in the intracellular calcium levels were monitored by loading infected cells with the fluorescent calcium indicator indo-1/AM and measuring the change in fluorescence, with an increase in relative fluorescence illustrating an increase in intracellular calcium. No change in intracellular calcium levels was seen upon the addition of RANTES in uninfected HF or in cells infected for 4 h with HCMV, while HF infected for 24 or 48 h demonstrated an increase in calcium with the addition of RANTES (Fig. 6A). In experiments with HV5.8, no calcium flux was detected with the addition of RANTES at any time point (Fig. 6B).
|
-chemokines other than RANTES
but not to
-chemokines (21). HF infected with HCMV were
tested for the generation of a calcium flux in response to MIP-1
(a
-chemokine) and IL-8 (an
-chemokine) (Fig. 6C). A response to
MIP-1
was detected, and a subsequent addition of RANTES did not give
a second calcium flux. The addition of IL-8 to HCMV-infected cells did
not elicit a calcium flux, but the subsequent addition of RANTES did
generate a response. In addition, an increase in intracellular calcium
was detected in response to the
-chemokines, MCP-1 and MIP-1
, but
to a lesser degree than to RANTES or MIP-1
(data not shown).
Northern analysis of US27 and US28. The binding and calcium flux data indicated that the US28 gene was expressed by 24 h postinfection. To confirm that this was true, the temporal expression of US28 and that of US27 were determined by Northern analysis of total RNA isolated from HF at 4, 24 and 48 h postinfection with HCMV (Towne) and at 48 h postinfection in the presence of ganciclovir. Figure 7 shows the Northern analysis of these samples with US27, or US28, derived probes. The US27 and US28 genes are transcribed in the same direction and terminate at a common polyadenylation signal at the end of US28, which results in a 2.9-kb US27 transcript and a 1.3-kb US28 transcript (57). No signal was detected in uninfected HF or at 4 h postinfection. A 1.3-kb transcript, corresponding to US28, was detected at 24 and 48 h postinfection, and a 2.9-kb transcript, from US27, was detected only at 48 h postinfection. In the presence of ganciclovir at 48 h postinfection only the 1.3-kb RNA was detected, identifying US28 as an early gene and US27 as a late gene.
|
US28 moderation of RANTES concentration in CMV-infected cultures. Human fibroblasts can be induced to produce RANTES by inoculation with tumor necrosis factor alpha (34) or CMV (32). The effect of US28 on the level of RANTES present in medium of infected cultures was determined by assaying the RANTES concentration in culture supernatants from HF, and HF infected with Towne, HV5.8, UV-inactivated virus, or heat-inactivated virus, at the time intervals indicated in Fig. 8. Uninfected HF and those infected with heat-inactivated virus produced minimally detectable levels of RANTES at all time points, while HF infected with Towne, HV5.8, and UV-inactivated virus showed a significant increase in RANTES by 8 h postinfection, with increased amounts at the 8- to 16-h interval. The level of RANTES in cultures infected with Towne rapidly declined after 16 h postinfection until 36 h postinfection, when levels were similar to those for uninfected cells. HV5.8-infected cells maintained a high level of RANTES through 36 h postinfection, but a reduction did occur 2 and 3 dpi. HF infected with UV-inactivated virus maintained elevated levels of RANTES expression at all time intervals.
|
| |
DISCUSSION |
|---|
|
|
|---|
It was previously demonstrated that cell lines expressing
recombinant US28 could bind
-chemokines and show a calcium flux in
the presence of chemokine ligands (21, 35). In this study, we demonstrate that human fibroblasts infected with HCMV gain the
functions consistent with those of a GCR that recognizes
-chemokines as a ligand. HCMV-infected cells bind RANTES, a
-chemokine, and respond to the addition of
-chemokines with the induction of an
intracellular calcium flux. Cells infected with a virus lacking US28
did not show these functions, demonstrating that the functions of a GCR
for
-chemokines seen in infected cells are due to US28 and not to
other viral genes or to an induced cellular gene.
It was found that US28 is an early gene, while US27 is a late gene. The
expression of the US28 transcript temporally corresponded to the
functions of a GCR for
-chemokines identified in HCMV-infected cells. The expression of the US28 mRNA at 24 h postinfection
contrasts with earlier work with AD169 indicating that both US28 and
US27 were late genes (57). Possible reasons for the
different results could be viral strain differences, the use of
ganciclovir instead of phosphonoformic acid (PFA), or that in the
previous work RNA was examined at only a single time point, 7 dpi, and
the extended PFA treatment may have had nonspecific effects. A recent
study in which PCR was used for the detection of RNA also suggested that the US28 gene is an early gene (32), but their methods could not distinguish between US27 or US28 as an early gene. It has
been postulated that the HCMV GCR may be constituents of the virion and
may account for the changes in intracellular calcium levels seen in
cells shortly after infection (57). While the UL33 protein
was shown to be a component of the virion (30), we did not
detect the activity of the US28 protein in the first few hours of
infection, indicating that the US28 protein is not a virion protein or
that it is present at too low a level to be detected by our methods.
Human fibroblasts are capable of producing RANTES (34), and inoculation of HF with CMV can induce RANTES expression (32). We found that the US28 gene has a profound effect on the level of RANTES present in the medium of infected cells. There was a rapid increase in RANTES present in culture supernatants from cells inoculated with Towne, HV5.8, or UV-inactivated virus, whereas a steep decline in RANTES was seen in Towne-infected cultures starting at the 16- to 24-h postinfection interval; the level in HV5.8 infected cultures remained elevated. However, a reduction of RANTES in supernatants of cultures infected with HV5.8 was seen at 2 and 3 dpi, compared to cultures infected with UV-inactivated virus, suggesting that factors other than US28 can contribute to lowered chemokine levels. While this result would support a role for US28 in reducing the immune response to sites of infection, it remains to be determined whether this is indicative of a true immune evasion function for US28 or simply an in vitro effect of the expression of a functional chemokine receptor by the virus.
Genes encoding GCR are a common theme in the genomes of gamma and beta
herpesviruses. The UL33, UL78, US27, and US28 ORFs of HCMV (15,
24), the U12 and U51 ORFs of human herpesvirus 6 (HHV-6)
(24), ORF 74 of HHV-8 (45), and ECRF3 of
herpesvirus saimiri (1) all have homology to cellular GCR.
Epstein-Barr virus, a gamma herpesvirus without a viral GCR, induces
the expression of two cellular GCR, EBI-1 and EBI-2 (8).
EBI-1 is also induced by HHV-6 and -7 (26). The ubiquitous
presence of GCR with beta and gamma herpesviruses suggests an important
role for these proteins in viral pathogenesis, but this role has not
yet been elucidated. Three possible functions have been suggested for
viral GCR: (i) immune evasion, (ii) cell activation, and (iii)
promotion of cell migration and virus dissemination. Our data showing
that HCMV-infected cells at early times after infection gain the
function of a GCR for
-chemokines can lend support to any of these
roles postulated for viral GCR.
Viral genes involved in immune evasion that mimic cellular functions
have been identified previously. Poxviruses express soluble proteins
that bind IL-1
and gamma interferon (3, 51, 53), and the
use of recombinant virus in animal models has shown that these proteins
can influence the host response (2, 3). It is possible that
the US28 protein sequesters chemokines, thereby reducing the host
immune response to sites of infection. The potential importance of
chemokines to the immune response is illustrated in transgenic mice
lacking the
-chemokine MIP-1
, in which a delayed clearance of
influenza virus was found (18). In support of its
functioning to adsorb chemokines, US28 was shown to have greater
binding affinity than CCR-1, one of the cellular receptors, for a
spectrum of
-chemokines (35, 45a). Our data demonstrating that the US28 gene can reduce the level of RANTES released by an
infected cell in vitro also support a possible role in immune evasion.
Although the US28 gene may function in immune evasion by binding
chemokines, the fact that the US28 protein transmits an intracellular
signal suggests that it also has other functions, since signal
transduction should not be required for sequestering chemokines alone.
The early kinetics of expression of US28 and the induction of processes involved in cell activation shown by the US28 protein are consistent with its having a role in activating a cell to allow or enhance viral replication. While CMV has been shown to replicate in a number of cell types that may express a chemokine receptor (10, 11, 19, 47), the superior binding of chemokines by the US28 GCR may be important for the activation of an infected cell at a level of ligand below that which activates uninfected cells. The US28 protein may also lead to the activation of cells by chemokines that do not naturally express a chemokine receptor.
Chemokines function as cell chemotactic agents in the induction of cell
adhesion to endothelium and the enhancement of cell migration across
the endothelium (6, 44). Thus, the US28 gene may function to
influence the migration of infected cells. The
-chemokines can act
as chemotactic agents for monocytes, T cells, and NK cells (4, 6,
29, 44), some of which can be infected by HCMV (10, 17, 19,
23, 27, 47, 48). The expression of the US28 protein would add to
infected cells a GCR with high affinity for a number of
-chemokines
(36). This receptor may therefore give infected cells an
improved or novel migratory ability and thereby contribute to virus
dissemination.
In the construction of the HCMV US28 mutant, the GFP was used as a marker that allowed the identification of recombinant plaques under UV illumination as well as the fluorescence-activated cell sorting of infected cells and the recovery of virus. Since the recombinant GFP gene, isolated from the jellyfish A. victoria (39), was first used as a genetic marker in Caenorhabditis elegans (13), it has been used in a variety of organisms, including yeast (5), mammalian cells (50), and transgenic mice (28). GFP is a valuable biological marker which allows a nonevasive detection that requires only illumination by UV light to yield green fluorescence. While the GFP is useful for the identification of recombinant virus, the greatest utility of GFP-tagged viruses may be for the noninvasive identification of infected cells. Future investigations on the functions of viral GCR will likely involve the study of monocytes and other cell populations in which only a subset of cells may be experimentally infected by CMV. In such cell populations, the GFP can allow the specific observation of infected cells or the isolation of infected cells for use in subsequent experiments regarding the study of viral GCR.
| |
ACKNOWLEDGMENT |
|---|
This study was supported in part by NIH grant AI26672 (awarded to A.P.G.).
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Fred Hutchinson Cancer Research Center, Program in Infectious Diseases, 1124 Columbia St., Seattle, WA 98104. Phone: (206) 667-6795. Fax: (206) 667-4411. E-mail: vieiraj{at}u.washington.edu.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Ahuja, S. K., and P. M. Murphy.
1993.
Molecular piracy of mammalian interleukin-8 receptor type B by herpesvirus saimiri.
J. Biol. Chem.
268:20691-20694 |
| 2. |
Alcam'i, A., and G. L. Smith.
1996.
A mechanism for the inhibition of fever by a virus.
Proc. Natl. Acad. Sci. USA
93:11029-11034 |
| 3. | Alcam'i, A., and G. L. Smith. 1992. A soluble receptor for interleukin-1 beta encoded by vaccinia virus: a novel mechanism of virus modulation of the host response to infection. Cell 71:153-167[Medline]. |
| 4. | Allavena, P., G. Bianchi, D. Zhou, J. van Damme, P. J'Ilek, S. Sozzani, and A. Mantovani. 1994. Induction of natural killer cell migration by monocyte chemotactic protein-1, -2 and -3. Eur. J. Immunol. 24:3233-3236[Medline]. |
| 5. | Atkins, D., and J. G. Izant. 1995. Expression and analysis of the green fluorescent protein gene in the fission yeast Schizosaccharomyces pombe. Curr. Genet. 28:585-588[Medline]. |
| 6. | Audran, R., T. Lesimple, M. Delamaire, C. Picot, J. Van Damme, and L. Toujas. 1996. Adhesion molecule expression and response to chemotactic agents of human monocyte-derived macrophages. Clin. Exp. Immunol. 103:155-160[Medline]. |
| 7. |
Baggiolini, M. B.,
B. Dewald, and B. Moser.
1994.
IL-8 and related chemotactic cytokines CXC and CC chemokines.
Adv. Immunol.
55:97-149[Medline].
|
| 8. |
Birkenbach, M.,
K. Josefsen,
R. Yalamanchili,
G. Lenoir, and E. Kieff.
1993.
Epstein-Barr virus-induced genes: first lymphocyte specific G protein-coupled peptide receptors.
J. Virol.
67:2209-2220 |
| 9. |
Bokoch, G. M.
1995.
Chemoattractant signaling and leukocyte activation.
Blood
86:1649-1660 |
| 10. |
Braun, R. W., and H. C. Reiser.
1986.
Replication of human cytomegalovirus in human peripheral blood T cells.
J. Virol.
60:29-36 |
| 11. | Brytting, M., M. Mousavi Jazi, L. Bostrom, M. Larsson, J. Lunderberg, P. Ljungman, O. Ringd'en, and V. A. Sundqvist. 1995. Cytomegalovirus DNA in peripheral blood leukocytes and plasma from bone marrow transplant recipients. Transplantation 60:961-965[Medline]. |
| 12. |
Carswell, S., and J. C. Alwine.
1989.
Efficiency of utilization of the simian virus 40 late polyadenylation site: effects of upstream sequences.
Mol. Cell. Biol.
9:4248-4258 |
| 13. |
Chalfie, M.,
Y. Tu,
G. Euskirchen,
W. W. Ward, and D. C. Prasher.
1994.
Green fluorescent protein as a marker for gene expression.
Science
263:802-805 |
| 14. | Chee, M. S., A. T. Bankier, S. Beck, R. Bohini, C. M. Brown, T. Cerny, T. Horsnell, C. A. Hutchinson III, T. Kouzarides, E. Martignetti, E. Preddie, S. C. Satchwell, P. K. M. Weston, and B. G. Barrell. 1990. Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169. Curr. Top. Microbiol. Immunol. 154:123-169. |
| 15. | Chee, M. S., S. C. Satchwell, E. Preddie, P. K. M. Weston, and B. G. Barrell. 1990. Human cytomegalovirus encodes three G protein-coupled receptor homologues. Nature 344:774-777[Medline]. |
| 16. | Chomezynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159[Medline]. |
| 17. | Cinatl, J., Jr., J. U. Vogel, J. Cinatl, B. Weber, H. Rabenau, M. Novak, B. Kornhuber, and H. W. Doerr. 1996. Long-term productive human cytomegalovirus infection of a human neuroblastoma cell line. Int. J. Cancer 65:90-96[Medline]. |
| 18. |
Cook, D. N.,
M. A. Beck,
T. M. Coffman,
S. L. Kirby,
J. F. Sheridan,
I. B. Pragnell, and O. Smithies.
1995.
Requirement of MIP-1 alpha for an inflammatory response to viral infection.
Science
269:1583-1585 |
| 19. | Dankner, W. M., J. A. McCutchan, D. D. Richman, K. Hirata, and S. A. Spector. 1990. Localization of human cytomegalovirus in peripheral blood leukocytes by in situ hybridization. J. Infect. Dis. 161:31-36[Medline]. |
| 20. | Fiers, W., R. Contreras, G. Haegemann, R. Rogiers, A. Van de Voorde, H. Van Heuverswyn, J. Van Herreweghe, G. Volckaert, and M. Ysebaert. 1978. Complete nucleotide sequence of SV40 DNA. Nature 273:113-120[Medline]. |
| 21. |
Gao, J. L., and P. M. Murphy.
1994.
Human cytomegalovirus open reading frame US28 encodes a functional beta chemokine receptor.
J. Biol. Chem.
269:28539-28542 |
| 22. |
Geballe, A. P.,
F. S. Leach, and E. S. Mocarski.
1986.
Regulation of cytomegalovirus late gene expression: genes are controlled by posttranscriptional events.
J. Virol.
57:864-874 |
| 23. | Gerna, G., D. Zipeto, E. Percivalle, M. Parea, M. G. Revello, R. Maccario, G. Peri, and G. Milanesi. 1992. Human cytomegalovirus infection of the major leukocyte subpopulations and evidence for initial viral replication in polymorphonuclear leukocytes from viremic patients. J. Infect. Dis. 166:1236-1244[Medline]. |
| 24. | Gompels, U. A., J. Nicholas, G. Lawrence, M. Jones, B. J. Thomson, M. E. Martin, S. Efstathiou, M. Craxton, and H. A. Macaulay. 1995. The DNA sequence of human herpesvirus-6: structure, coding content, and genome evolution. Virology 209:29-51[Medline]. |
| 25. |
Greaves, R. F.,
J. M. Brown,
J. Vieira, and E. S. Mocarski.
1995.
Selectable insertion and deletion mutagenesis of the human cytomegalovirus genome using the Escherichia coli guanosine phosphoribosyl transferase (gpt) gene.
J. Gen. Virol.
76:2151-2160 |
| 26. |
Hasegawa, H.,
Y. Utsunomiya,
M. Yasukawa,
K. Yanagisawa, and S. Fujita.
1994.
Induction of G protein-coupled peptide receptor EBI 1 by human herpersvirus 6 and 7 infection in CD4+ T cells.
J. Virol.
68:5326-5329 |
| 27. |
Ibanez, C. E.,
R. Schrier,
P. Ghazal,
C. Wiley, and J. A. Nelson.
1991.
Human cytomegalovirus productively infects primary differentiated macrophages.
J. Virol.
65:6581-6588 |
| 28. | Ikawa, M., K. Kominami, Y. Yoshimura, K. Tanaka, Y. Nishimune, and M. Okabe. 1995. A rapid and non-invasive selection of transgenic embryos before implantation using green fluorescent protein (GFP). FEBS Lett. 375:125-128[Medline]. |
| 29. | Loetscher, P., M. Seitz, I. Clark Lewis, M. Baggiolini, and B. Moser. 1996. Activation of NK cells by CC chemokines. Chemotaxis, Ca2+ mobilization, and enzyme release. J. Immunol. 156:322-327[Abstract]. |
| 30. | Margulies, B. J., H. Browne, and W. Gibson. 1996. Identification of the human cytomegalovirus G protein-coupled receptor homologue encoded by UL33 in infected cells and enveloped virus particles. Virology 225:111-125[Medline]. |
| 31. |
McGeoch, D. J.,
M. A. Dalrymple,
A. J. Davison,
A. Dolan,
M. C. Frame,
D. McNab,
L. J. Perry,
J. E. Scott, and P. Taylor.
1988.
The complete DNA sequence of the long unique region in the genome of the herpes somplex virus type 1.
J. Gen. Virol.
69:1531-1574 |
| 32. | Michelson, S., P. Dal Monte, D. Zipeto, B. Bodaghi, L. Laurent, E. Oberlin, F. Arenzana-Seisdedos, J.-L. Virelizier, and M. P. Landini. 1997. Modulation of RANTES production by human cytomegalovirus infection of fibroblasts. J. Virol. 71:6495-6500[Abstract]. |
| 33. | Myerson, D., R. C. Hackman, J. A. Nelson, D. C. Ward, and J. K. McDougal. 1984. Widespread presence of histologically occult cytomegalovirus. Hum. Pathol. 15:430-439[Medline]. |
| 34. | Nelson, P. J., H. T. Kim, W. C. Manning, T. J. Goralski, and A. M. Krensky. 1993. Genomic organization and transcriptional regulation of the RANTES chemokine gene. J. Immunol. 151:2601-2612[Abstract]. |
| 35. |
Neote, K.,
W. Darbonne,
J. Ogez,
R. Horuk, and T. J. Schall.
1993.
Identification of a promiscuous inflammatory peptide receptor on the surface of red blood cells.
J. Biol. Chem.
268:12247-12249 |
| 36. | Neote, K., D. DiGregorio, J. Y. Mak, R. Horuk, and T. J. Schall. 1993. Molecular cloning, functional expression, and signaling characteristics of a C-C chemokine receptor. Cell 72:415-425[Medline]. |
| 37. | Nicholas, J., K. R. Cameron, and R. W. Honess. 1992. Herpesvirus saimiri encodes homologues of G protein-coupled receptors and cyclins. Nature 355:362-365[Medline]. |
| 38. |
Nudel, U.,
R. Zakut,
S. Neuman,
Z. Levy, and D. Yaffe.
1983.
The nucleotide sequence of the rat cytoplasmic -actin gene.
Nucleic Acids Res.
11:1759-1768 |
| 39. | Prasher, D. C., C. K. Eckenrode, W. W. Ward, F. G. Prendergast, and M. J. Cormier. 1992. Primary structure of the Aequorea victoria green fluorescent protein. Gene 111:229-233[Medline]. |
| 40. |
Pratt, D., and S. Subramani.
1983.
Nucleotide sequence of the Escherichia coli xanthine-guanine phosphoribosyl transferase gene.
Nucleic Acids Res.
11:8817-8823 |
| 41. | Pritchard, M., and E. S. Mocarski. Personal communication. |
| 42. | Retzel, E., A. Evanelista, S. Maroushek, H. Minnigan, A. Larson, A. T. Haase, D. Gonzalez-Dunia, D. McFarlin, E. Mingiolo, S. Jacabson, M. Osame, and S. Sonoda. 1990. Nucleotide sequence analysis of a provirus derived from an individual with tropical spastic paraparesis. Microb. Pathog. 8:259-278[Medline]. |
| 43. |
Robb, R. J.,
W. C. Greene, and C. M. Rusk.
1984.
Low and high affinity receptors for interleukin 2.
J. Exp. Med.
160:1126-1146 |
| 44. | Roth, S. J., M. W. Carr, and T. A. Springer. 1995. C-C chemokines, but not the C-X-C chemokines interleukin-8 and interferon-gamma inducible protein-10, stimulate transendothelial chemotaxis of T lymphocytes. Eur. J. Immunol. 25:3482-3488[Medline]. |
| 45. |
Russo, J. J.,
R. A. Bohensky,
M.-C. Chien,
J. Chen,
M. Yan,
D. Maddalena,
J. P. Parry,
D. Peruzzi,
I. S. Edelman,
C. Yuan, and P. S. Moore.
1996.
Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8).
Proc. Natl. Acad. Sci. USA
93:14862-14867 |
| 45a. | Schall, T. Unpublished observations. |
| 46. | Schall, T. J., and K. B. Bacon. 1994. Chemokines, leukocyte trafficking, and inflammation. Curr. Opin. Immunol. 6:865-873[Medline]. |
| 47. |
Schrier, R. D.,
J. A. Nelson, and M. B. Oldstone.
1985.
Detection of human cytomegalovirus in peripheral blood lymphocytes in a natural infection.
Science
230:1048-1051 |
| 48. |
Soderberg, C.,
S. Larsson,
S. Bergstedt Lindqvist, and E. Moller.
1993.
Definition of a subset of human peripheral blood mononuclear cells that are permissive to human cytomegalovirus infection.
J. Virol.
67:3166-3175 |
| 49. |
Spate, R. R., and E. S. Mocarski.
1987.
Insertion and deletion mutagenesis of the human cytomegalovirus genome.
Proc. Natl. Acad. Sci. USA
84:7213-7217 |
| 50. | Stauber, R., G. A. Gaitanaris, and G. N. Pavlakis. 1995. Analysis of trafficking of Rev and transdominant Rev proteins in living cells using green fluorescent protein fusions: transdominant Rev blocks the export of Rev from the nucleus to the cytoplasm. Virology 213:439-449[Medline]. |
| 51. | Symons, J. A., A. Alcam'i, and G. L. Smith. 1995. Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species specificity. Cell 81:551-560[Medline]. |
| 52. |
Taylor-Wiedeman, J.,
J. G. Sissons,
L. K. Borysiewicz, and J. H. Sinclair.
1991.
Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells.
J. Gen. Virol.
72:2059-2064 |
| 53. |
Upton, C.,
K. Mossman, and G. McFadden.
1992.
Encoding of a homolog of the IFN-gamma receptor by myxoma virus.
Science
258:1369-1372 |
| 54. |
van der Hoff, M. J. B.,
A. F. M. Moorman, and W. H. Lamers.
1992.
Electorporation in `intracellular' buffer increases cell survival.
Nucleic Acids Res.
20:2902 |
| 55. |
Vieira, J.,
H. E. Farrell,
W. D. Rawlinson, and E. S. Mocarski.
1994.
Genes in the HindIII J fragment of the murine cytomegalovirus genome are dispensable for growth in cultured cells: insertion mutagenesis with a lacZ/gpt cassette.
J. Virol.
68:4837-4846 |
| 56. | Vieira, J. Unpublished data. |
| 57. |
Welch, A. R.,
L. M. McGregor, and W. Gibson.
1991.
Cytomegalovirus homologs of cellular G protein-coupled receptor genes are transcribed.
J. Virol.
65:3915-3918 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | Mol. Cell. Biol. |
|---|